Lyophilization Technology, Inc. (LTI) is a Contract Development & Manufacturing Organization (CDMO) focused on all aspects of lyophilization for preparation of health care products.
To Plan, Secure and Serve:
During this uncertain and unnerving time of living and working through the pandemic our best defense in battling COVID-19 is science, evidence, and reason. With a responsible attitude, plans and measures have been put in place to protect our most valuable asset and resource; the LTI staff. As responsible professionals with significant demands, we have altered our work habits, all showing up for work, whether it be on site or working from home, sometimes working irregular schedules, and sometimes long hours. We have arranged activities to allow us to continue supporting our client's endeavors, keeping development projects on track and on time.
As we continue to live through this public health emergency and learn more about the epidemiology of SARS-CoV-2, we constantly adjust these safe measures and plans to deal with what has become our more common routine. We will continue to strive to protect ourselves and secure our ability to provide services to our clients. We recognize the role we play and our responsibilities in the development of new products for the benefit of current and future patients. We realize bringing a new product to patients is a long-term endeavor. We are committed to assure our services are available to our clients and we are not deterred by these hopefully soon to end conditions.
Continued Client Services:
LTI has had enhanced safety measures for the protection of staff and the ability to continue capable and safe operations to serve our clients. Recognizing the importance of carrying on new product development and preparing material for patients awaiting new therapies in clinical trials, LTI staff continues to be diligent in their practices to keep everyone safe. These include split work schedules, use of face coverings, enhanced air handling and cleaning/sanitizing, social distancing, barriers between workstations, and widespread access to hand sanitizer. The staff will continue the rigorous efforts to avoid the spread of the viral infection to our colleagues and families. We remain a viable operation in continuing to provide our clients the services they count upon for bringing new products to patients in need.
The 2021 Martin Van Trieste Pharmaceutical Science Award is to be bestowed on Edward Trappler, President, Lyophilization Technology, Inc. in conjunction with the upcoming Parenteral Drug Association (PDA) Annual Meeting. The award recognizes individuals for "Outstanding Contributions to the Advancement of Pharmaceutical Science for the Parenteral Drug Association".